Semler Scientific, Inc. (NASDAQ:SMLR) Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp increased its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 10.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,618 shares of the company’s stock after acquiring an additional 1,940 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.29% of Semler Scientific worth $709,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CWM LLC increased its stake in shares of Semler Scientific by 486.3% in the second quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after purchasing an additional 744 shares during the period. BOKF NA acquired a new stake in shares of Semler Scientific in the first quarter valued at approximately $227,000. Horizon Investment Services LLC increased its stake in shares of Semler Scientific by 35.8% in the first quarter. Horizon Investment Services LLC now owns 8,352 shares of the company’s stock valued at $244,000 after purchasing an additional 2,203 shares during the period. Truvestments Capital LLC acquired a new stake in shares of Semler Scientific in the first quarter valued at approximately $263,000. Finally, Financial Strategies Group Inc. acquired a new stake in shares of Semler Scientific in the second quarter valued at approximately $263,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Trading Down 4.7 %

Shares of NASDAQ:SMLR opened at $23.33 on Monday. The firm’s 50 day moving average is $28.62 and its two-hundred day moving average is $29.22. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $53.38. The firm has a market capitalization of $163.08 million, a P/E ratio of 8.36 and a beta of 0.96.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.08. The business had revenue of $14.47 million during the quarter. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%.

Insiders Place Their Bets

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the sale, the chief executive officer now owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 13.00% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.